« Previous
Next »
Journal of Vascular and Interventional Radiology
Volume 20, Issue 7
, Pages 896-902
, July 2009
Arterial Chemoembolization/Embolization and Early Complications after Hepatocellular Carcinoma Treatment: A Safe Standardized Protocol in Selected Patients with Child Class A and B Cirrhosis
References
- . Global cancer statistics 2002. CA Cancer J Clin. 2005;55:74–108
- . Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429–442
- Transarterial therapy for hepatocellular carcinoma: which technique is more effective? (A systematic review of cohort and randomized studies). Cardiovasc Intervent Radiol. 2007;30:6–25
- . A comparison of Lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med. 1995;332:1256–1261
- . Transcatheter arterial chemoembolization in inoperable hepatocellular carcinoma: four-year follow up. J Vasc Interv Radiol. 1996;7:419–425
- A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol. 1990;11:181–184
- A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. Cancer. 2000;88:50–57
- . Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol. 2000;73:109–114
- Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734–1739
- . A prospective study regarding the complications of transcatheter intraarterial Lipiodol chemoembolization in patients with hepatocellular carcinoma. Cancer. 2002;94:1747–1752
- High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. World J Gastroenterol. 2002;8:74–78
- Comparison of transcatheter arterial chemoembolization, laparoscopic radiofrequency ablation, and conservative treatment for decompensated cirrhotic patients with hepatocellular carcinoma. World J Gastroenterol. 2004;10:505–508
- . Outcome of transarterial chemoembolization in patients with inoperable hepatocellular carcinoma eligible for radiofrequency ablation. World J Gastroenterol. 2005;11:4465–4471
- Chemoembolization in patients at high risk: results and complications. J Vasc Interv Radiol. 2006;17:47–53
- Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol. 2007;18:1469–1478
- Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–655
- Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL Conference. J Hepatol. 2001;35:421–430
- Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of the therapeutic trials. Hepatology. 1999;29:62–67
- . Model for end-stage liver disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg. 2005;242:244–251
- . Hepatitis B virus reactivation after a single session of transarterial chemoembolization in patients with hepatocellular carcinoma (Research letter). Ann Intern Med. 2003;138:691–692
- Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma. World J Gastroenterol. 2007;13:2952–2955
- . Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors. J Clin Gastroenterol. 1999;28:334–340
- Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and epirubicin pharmacokinetics. J Hepatol. 2007;46:474–481
- Transarterial chemoembolization of unresectable hepatocellular carcinoma (HCC) with drug eluting beads (DEB): results of an open label study of 62 patients. Cardiovasc Intervent Radiol. 2008;31:269–280
None of the authors have identified a conflict of interest.
PII: S1051-0443(09)00331-5
doi: 10.1016/j.jvir.2009.03.032
© 2009 SIR. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Vascular and Interventional Radiology
Volume 20, Issue 7
, Pages 896-902
, July 2009
